FOLD

#1389
Amicus Therapeutics, Inc
14.4600 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
14.4600
14.4600
Rango anual
8.6200
14.4800
Cambio diario
0.00%
Variación mensual
+0.63%
Variación en los últimos 6 meses
+66.97%
Cambio anual
+66.97%
Cierres anteriores
14.4600
Abrir
14.4600
Bid
Ask
Mínimo
14.4600
High
14.4600
Volumen
74
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 4.5405 B
  • Employee 511
  • Founded 2002
  • CEO Bradley L Campbell
  • Website www.amicusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG000PLF6N0
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-158.22
Relación precio/flujo de caja
6.92

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Noticias